Study on the Effect of Incentive Spirometer-based Respiratory Training on the Long COVID-19

The COVID-19 pandemic has emerged as the most significant public health crisis of the 21st century. As of the end of January 2023, global confirmed cases have exceeded 670 million, with a domestic cumulative total of 10.24 million cases, including occurrences of reinfection. Beyond acute symptoms following infection, patients and society face the challenge of long-term complications associated with COVID-19. Termed 'Post COVID-19 condition' or 'Long COVID' by the World Health Organization (WHO), this encompasses symptoms appearing within three months of the initial infection. Symptoms of Long COVID reveal chronic damage inflicted by the virus on multiple organ systems, including fatigue, cognitive impairment, chest tightness, palpitations, difficulty breathing, and depression. Despite continuous efforts by healthcare professionals to find suitable treatments, no medication has been confirmed to effectively prevent or reduce post-COVID-19 sequelae. These health issues impose significant burdens and disturbances on patients' quality of life, economies, and societies.

NCT Number	NCT06231225
Lead Sponsor	National Taipei University of Nursing and Health Sciences Collaborators: Tri-Service General Hospital (TSGH)
Conditions	COVID-19 Pandemic, Diabetes, Hypertension, Cardiac Disease, Long COVID
Enrollment	100 participants
Start Date	2024-07-01
Primary Completion	2025-06-30 (estimated)
Study Completion	2026-08-01 (estimated)
Updated on ClinicalTrials.gov	2024-01-30